Ruth R. Cheng, PhD, succeeds Raymond H. Cypess, DVM, PhD, who will remain on the Board of Directors as chairman Dr. Cheng is an experienced global executive leader in life sciences innovation and business strategy, with a strong background in biology and biomedical engineering MANASSAS, Va. — ATCC, the world’s premier biological materials management and standards […]
Experienced healthcare leader with more than 20 years of demonstrated success driving industry growth and transformation takes helm at global genomics company CORALVILLE, Iowa and REDWOOD CITY, Calif. — Global genomics solutions leader Integrated DNA Technologies (IDT) has appointed Ajay Gannerkote as president, effective immediately. With a track record of driving growth and transformation across myriad […]
Oxford Instruments plc (“the Company”), a global provider of high technology products and services to many of the world’s leading companies and scientific research communities, today announces succession plans for the role of Chief Financial Officer (“CFO”) to the Company. After nearly nine years with the Company, Gavin Hill has agreed with the Board that […]
Simon Egli Appointed Chief Executive Officer as Co-Founder Pascal Behr Transitions to Board of Directors Zürich, Switzerland – Cytosurge AG, a leader in single-cell manipulation, a biotech company pioneering innovative single-cell biopsies and cell-line engineering solutions, announces a leadership transition effective January 1, 2025. Pascal Behr, Ph.D., co-founder and CEO for 12 years, remains on the […]
— Nirrin Technologies, a developer of analytical tools poised to transform bioprocess analysis, today announced the founding of its Scientific Advisory Board (SAB), with key experts in diverse fields across biomanufacturing and advanced therapeutic development joining as inaugural members. The SAB will provide technical and strategic guidance for ongoing research and development programs and shape plans for […]
Dr Jose-Carlos Gutiérrez-Ramos is the Chief Science Officer at Danaher Corporation. He has held senior drug discovery roles at Pfizer, Abbvie, and GSK. As CEO and President of Synlogic, he led the company from early drug discovery to clinical stage and public markets He brings a wealth of experience across biotechs and pharmaceutical companies, combined with […]
London, UK – LGC has today announced that Joydeep Goswami is joining its Board of Directors and Executive Leadership Team (ELT) as President and Chief Executive Officer (CEO). Joydeep succeeds Euan O’Sullivan, who decided to step down from his role in early 2024 after fourteen years of outstanding and dedicated service. Euan has worked closely with […]
Appointment signals acceleration of organic and inorganic growth for VION as it looks to expand in 2025 CHARLOTTESVILLE, Va. — VION Biosciences, a life science platform company focused on specialty materials in the life science research, diagnostics, and drug discovery spaces, today announced Vince Stoyanov as its Chief Strategy and Development Officer. He will lead […]
ROCKVILLE, MD – MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that Art Mandell has retired from his position as a member of the Board of Directors of MaxCyte effective December 31, 2024. Mr. Mandell […]
Rapid platform adoption with over 50 biopharma and academic partners to date, including 7 of the top 10 pharmaceutical companies Oversubscribed $7M financing proceeds, coupled with revenue, to drive continued growth and launch of next generation products Anil Narasimha, Ph.D. joins as Chief Commercial Officer CAMBRIDGE, Mass.–Today, Portal Biotechnologies, Inc. (“Portal”), a cell engineering platform […]
Pay Invoice
Latest Blogs
-
LAUDA: Temperature Control Innovation
December 10, 2024 4:11 pm
-
Perseverance Forecasted for the Pharmaceutical Market for Analytical and Scientific Instrumentation
October 24, 2024 5:17 pm
-
M&A Activity in the Analytical Instrumentation and Lab Tools Market. 2021-2023
September 30, 2024 1:32 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
